VectoMax FG seamlessly combines two potent bacterial strains, Bacillus thuringiensis subsp. israelensis (Bti, strain AM65-52) and Bacillus sphaericus 2362 (Bs, strain ABTS 1743), to create an effective solution in fight against mosquitoes.
The Science Behind VectoMax FG: BioFuse™ Technology
Valent BioSciences’ VectoMax FG employs BioFuse™ technology, a patented formulation process that combines these two bacterial strains into a single microparticle. This technology ensures that each particle carries a calculated ratio of Bti and Bs toxins, a blend that delivers a one-two punch against mosquito larvae.
In addition to these effective active ingredients, the product incorporates food-grade inert substances, garnering its approval for application in sensitive habitats and organic crops throughout the world.
The Power of Two: Bti and Bs Toxins
VectoMax FG harnesses the unique strengths of both Bti and Bs strains. The Bti strain, known for its broad-spectrum activity against mosquitoes, delivers a rapid response and carries a low resistance potential. Bs provides extended residual control, high target specificity, and remains effective in polluted waters.
The Biology of Bti and Bs
In their fight against mosquito larvae, both strains produce complex crystal proteins, or protoxins, during sporulation. These protoxins, when ingested by mosquito larvae, turn into active peptide toxins known as delta-endotoxins in the larval midgut. These delta-endotoxins create holes in the midgut cell wall, leading to cell lysis and eventually larvae death.
The action of Bti is swift, showing results within 2-24 hours, while Bs acts more slowly but has a long-lasting effect. The union of these two strains in VectoMax FG offers an effective solution, combining Bti’s quick kill action with the residual control of Bs.
VectoMax FG: A Shield Against Disease Vectors
VectoMax FG’s potency extends to a range of mosquito species of public health significance, including Culex and Aedes species. The Culex species are carriers of West Nile virus and various forms of encephalitis, such as St. Louis encephalitis and Japanese encephalitis. Aedes species, on the other hand, are responsible for transmitting diseases like Zika, dengue, yellow fever, and chikungunya.
This product is particularly effective in habitats like sewage treatment settling pond, catch basins, and floodwater areas, where water tends to linger, and organic content is high. The distinct size, shape, and density of VectoMax FG particles minimize the potential for off-target application due to aerial drift while ensuring good penetration of dense vegetation.
Closing Thoughts
As we conclude our exploration of VectoMax FG, it’s clear that this product, born from a fusion of nature and technology, offers a significant advance in our battle against mosquito-borne diseases. By harnessing the unique strengths of Bti and Bs strains and utilizing the cutting-edge BioFuse™ technology, VectoMax FG effectively tackles mosquito populations, curbing the diseases they transmit.
The fascinating biology of Bti and Bs and their modes of action against mosquito larvae underscore the remarkable role of nature in shaping our tools for disease control. When paired with human ingenuity and technological advancements, we have a potent weapon in our arsenal for combating mosquito-borne diseases.
Azelis A&ES has technical experts that can help you select the right solution to control problem vectors in your region. We are ready to share our knowledge and experience with you!